The Affiliated Hospital Of Xuzhou Medical University
Clinical trials sponsored by The Affiliated Hospital Of Xuzhou Medical University, explained in plain language.
-
Early evolocumab after stroke thrombolysis: can it stop brain deterioration?
Disease control CompletedThis study looked at whether giving evolocumab (a powerful cholesterol-lowering injection) within 24 hours after clot-busting drugs can prevent early neurological worsening in people with acute stroke caused by large artery blockage. 132 adults were enrolled and randomly assigned…
Phase: PHASE4 • Sponsor: The Affiliated Hospital of Xuzhou Medical University • Aim: Disease control
Last updated May 17, 2026 03:27 UTC
-
New drug combo after stroke shows promise in preventing early brain decline
Disease control CompletedThis study tested whether giving a powerful cholesterol-lowering drug (evolocumab) within 6 hours after stroke clot removal could prevent early neurological worsening. 60 adults with large-vessel stroke were randomly assigned to receive either the drug plus standard care or stand…
Phase: PHASE4 • Sponsor: The Affiliated Hospital of Xuzhou Medical University • Aim: Disease control
Last updated May 11, 2026 20:50 UTC